BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25455854)

  • 1. Pharmacokinetics of fluconazole in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration.
    Sinnollareddy MG; Roberts MS; Lipman J; Robertson TA; Peake SL; Roberts JA
    Int J Antimicrob Agents; 2015 Feb; 45(2):192-5. PubMed ID: 25455854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of piperacillin in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration.
    Sinnollareddy MG; Roberts MS; Lipman J; Peake SL; Roberts JA
    J Antimicrob Chemother; 2018 Jun; 73(6):1647-1650. PubMed ID: 29506150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of sustained low-efficiency diafiltration (SLED-f) on interstitial fluid concentrations of fluconazole in a critically ill patient: Use of microdialysis.
    Sinnollareddy MG; Roberts MS; Lipman J; Peake SL; Roberts JA
    Int J Antimicrob Agents; 2015 Jul; 46(1):121-4. PubMed ID: 25888463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approach.
    Gharibian KN; Mueller BA
    Clin Nephrol; 2016 Jul; 86(7):43-50. PubMed ID: 27251341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low-Efficiency Dialysis.
    Rider TR; Silinskie KM; Hite MS; Bress J
    Pharmacotherapy; 2020 Oct; 40(10):1036-1041. PubMed ID: 32866291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole pharmacokinetics in a morbidly obese, critically ill patient receiving continuous venovenous hemofiltration.
    Lopez ND; Phillips KM
    Pharmacotherapy; 2014 Sep; 34(9):e162-8. PubMed ID: 25074285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis.
    Kanji S; Roberts JA; Xie J; Zelenitsky S; Hiremath S; Zhang G; Watpool I; Porteous R; Patel R
    Clin Pharmacokinet; 2020 Mar; 59(3):327-334. PubMed ID: 31471789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy.
    Marshall MR; Golper TA; Shaver MJ; Alam MG; Chatoth DK
    Kidney Int; 2001 Aug; 60(2):777-85. PubMed ID: 11473662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching from continuous veno-venous hemodiafiltration to intermittent sustained low-efficiency daily hemodiafiltration (SLED-f) in pediatric acute kidney injury: A prospective cohort study.
    Sethi SK; Raina R; Bansal SB; Soundararajan A; Dhaliwal M; Raghunathan V; Kalra M; Soni K; Mahato SK; Vadhera A; Yadav DK; Bunchman T
    Hemodial Int; 2023 Jul; 27(3):308-317. PubMed ID: 37096552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study.
    Kitchlu A; Adhikari N; Burns KE; Friedrich JO; Garg AX; Klein D; Richardson RM; Wald R
    BMC Nephrol; 2015 Aug; 16():127. PubMed ID: 26238520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy.
    Marshall MR; Golper TA; Shaver MJ; Alam MG; Chatoth DK
    Am J Kidney Dis; 2002 Mar; 39(3):556-70. PubMed ID: 11877575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO study.
    Novy E; Abdul-Aziz MH; Cheng V; Burrows F; Buscher H; Corley A; Diehl A; Gilder E; Levkovich BJ; McGuinness S; Ordonez J; Parke R; Parker S; Pellegrino V; Reynolds C; Rudham S; Wallis SC; Welch SA; Fraser JF; Shekar K; Roberts JA
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0120123. PubMed ID: 38063399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of continuous venovenous haemofiltration and haemodiafiltration on the elimination of fluconazole in patients with acute renal failure.
    Valtonen M; Tiula E; Neuvonen PJ
    J Antimicrob Chemother; 1997 Nov; 40(5):695-700. PubMed ID: 9421318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
    Roberts JA; Udy AA; Bulitta JB; Stuart J; Jarrett P; Starr T; Lassig-Smith M; Roberts NA; Dunlop R; Hayashi Y; Wallis SC; Lipman J
    J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients.
    Alobaid AS; Wallis SC; Jarrett P; Starr T; Stuart J; Lassig-Smith M; Mejia JL; Roberts MS; Sinnollareddy MG; Roger C; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6550-6557. PubMed ID: 27550344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam pharmacokinetics in critically ill patients undergoing renal replacement therapy.
    Chappell K; Kimmons LA; Haller JT; Canada RB; He H; Hudson JQ
    J Crit Care; 2021 Feb; 61():216-220. PubMed ID: 33217623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy.
    Marshall MR; Ma T; Galler D; Rankin AP; Williams AB
    Nephrol Dial Transplant; 2004 Apr; 19(4):877-84. PubMed ID: 15031344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
    Muhl E; Martens T; Iven H; Rob P; Bruch HP
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study.
    Braune S; König C; Roberts JA; Nierhaus A; Steinmetz O; Baehr M; Kluge S; Langebrake C
    Crit Care; 2018 Jan; 22(1):25. PubMed ID: 29382394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Archetypal sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring kidney replacement therapy: towards an adequate therapy.
    Sethi S; Mangat G; Soundararajan A; Marakini AB; Pecoits-Filho R; Shah R; Davenport A; Raina R
    J Nephrol; 2023 Sep; 36(7):1789-1804. PubMed ID: 37341966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.